As the "experts" continue to tout how safe and effective vaccinations are, something will get leaked. This news story is important as it shows the "experts" do not truly know or understand how vaccinations affect everyone entirely. It's safe for them to state that they are safe because the majority of children tolerate them. However, there are no long terms studies showing what these deadly chemicals and other ingredients are doing to our bodies in the long term.
What these doctors and other so called experts neglect to understand that although vaccinations are served up as a "one size fits all" program, they do not. Babies and children are dying from reactions to the vaccines and when the reason is not obvious, a caregive is being convicted under the guise of shaken baby syndrome or blunt force impact or whatever name the prosecution will utilize to sustain a conviction at all costs.
How about finding the real cause instead of being on a deadly witch hunt to convict someone? How about convicting the doctors or nurses that give these vaccines that cause injury or deaths? Perhaps if the doctors ran every imaginable test possible to rule out an underlying medical condition, a child might live or a person won't be wrongfully convicted. Has it been considered that doctors treating for SBS are the reasons why the child died? You have to treat for the correct diagnosis.
From Health Freedom Alliance:
An eight year study conducted at the Mayo Clinic, published by the American Thoracic Society suggests that there is a correlation between flu shots and risk of complications from influenza. The study evaluated every pediatric patient that was seen at the Mayo Clinic over the course of eight flu seasons to determine how much the flu shot prevented hospitalization from influenza in asthmatic children. ATS 2009, SAN DIEGO— The inactivated flu vaccine does not appear to be effective in preventing influenza-related hospitalizations in children, especially the ones with asthma. In fact, children who get the flu vaccine are more at risk for hospitalization than their peers who do not get the vaccine, according to new research that will be presented on Tuesday, May 19, at the 105th International Conference of the American Thoracic Society in San Diego.
Flu vaccine (trivalent inactivated flu vaccine—TIV) has unknown effects on asthmatics.
“The concerns that vaccination maybe associated with asthma exacerbations have been disproved with multiple studies in the past, but the vaccine’s effectiveness has not been well-established,” said Avni Joshi, M.D., of the Mayo Clinic in Rochester, MN. “This study was aimed at evaluating the effectiveness of the TIV in children overall, as well as the children with asthma, to prevent influenza-related hospitalization.”
The CDC’s Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) recommend annual influenza vaccination for all children aged six months to 18 years.
The National Asthma Education and Prevention Program (3rd revision) also recommends annual flu vaccination of asthmatic children older than six months. In order to determine whether the vaccine was effective in reducing the number of hospitalizations that all children, and especially the ones with asthma, faced over eight consecutive flu seasons, the researchers conducted a cohort study of 263 children who were evaluated at the Mayo Clinic in Minnesota from six months to 18 years of age, each of whom had had laboratory-confirmed influenza between 1996 to 2006. The investigators determined who had and had not received the flu vaccine, their asthma status and who did and did not require hospitalization. Records were reviewed for each subject with influenza-related illness for flu vaccination preceding the illness and hospitalization during that illness.
They found that children who had received the flu vaccine had three times the risk of hospitalization, as compared to children who had not received the vaccine. In asthmatic children, there was a significantly higher risk of hospitalization in subjects who received the TIV, as compared to those who did not (p= 0.006). But no other measured factors—such as insurance plans or severity of asthma—appeared to affect risk of hospitalization.
“While these findings do raise questions about the efficacy of the vaccine, they do not in fact implicate it as a cause of hospitalizations,” said Dr. Joshi. “More studies are needed to assess not only the immunogenicity, but also the efficacy of different influenza vaccines in asthmatic subjects.”
Session # C94: “Viral Infections in Childhood Respiratory Disease”
Abstract # 561: “Flu Vaccination in Asthmatics: Does It Work?”
http://www.call4abstracts.com/ats/society_admin/abs_preview.php?absnum=561
Close Window
ATS 2009 · San Diego
International Conference
Abstract Number: 561
Contact/Presenting Author: Avni Y. Joshi
Department/Institution: Internal Medicine, Mayo Clinic
Address: 200, First St. SW
City/State/Zip/Country: Rochester, MN, 55905
Phone: 01-507-284-2511 Fax: 01-507-284-0902 E-mail: joshi.avni@mayo.edu
ATS member: No Student or in training: Yes
Funding Source: None.
Abstract Category: 14.03 - Pediatric Asthma
Presentation format: Either Poster or Oral
Preview Disclosure
Travel Award: Yes
Publication of email address: Yes, joshi.avni@mayo.edu
I confirm that all authors listed on this abstract have knowledge of the abstract submission:
Yes
Title: Flu Vaccination in Asthmatics: Does It Work?
A. Y. Joshi, MD1, V. N. Iyer, MD,MPH1, M. F. Hartz, MD1, G. W. Volcheck, MD,Ph.D1, A. M. Patel,
MD1 and J. T. Li, MD,Ph.D1. 1Mayo Clinic College of Medicine, Rochester, MN.
INTRODUCTION: Influenza is known to be associated with asthma exacerbation but the
effectiveness of the trivalent inactivated flu vaccine (TIV) in asthmatics is unknown.
METHODS: We conducted a cohort study of all pediatric subjects( 6 months to 18 years age)
who were evaluated at Mayo Clinic, Rochester, MN, USA who had laboratory confirmed influenza
during each flu season from 1999-2006 to evaluate the efficacy of TIV. A case control analysis
was performed with the cases and the controls being the subjects with asthma who did and did not
required hospitalization with the influenza illness respectively.
RESULTS:
There were 236 subjects with laboratory confirmed influenza from 1996-2006.
In assessing the effectiveness of the TIV for preventing hospitalization with influenza in all
subjects, there was an overall trend towards higher rates of hospitalization in subjects who got the
TIV as compared to the ones who did not get the TIV( OR:2.97, CI: 1.3,6.7).Using Cochran-Mantel-
Haenszel (CMH) test for Asthma status stratification, there was a significant association between
hospitalization in asthmatic subjects and TIV (P=0.006).
http://www.call4abstracts.com/ats/society_admin/abs_preview.php?absnum=561 (1 of 2) [5/11/2009 1:43:56 PM]
http://www.call4abstracts.com/ats/society_admin/abs_preview.php?absnum=561
In the asthmatic subset:
There was no association between ER visit and receiving the TIV ,severity of asthma and the risk
of hospitalization or the hospital length of stay and receiving the TIV.
In assessing access to medical care, there was no association between hospitalizations and
health care insurance plans (Odds ratio:0.3, P= 0.13)
CONCLUSION:
1) TIV did not provide any protection against hospitalization in pediatric subjects’ esp. children with
asthma. On the contrary, we found a 3- fold increased risk of hospitalization in subjects who did
get the TIV vaccine.This may be a reflection not only of the vaccine effectiveness but also the
population of children who are more likely to get the vaccine.
2) More studies are needed to assess not only the immunogenicity but also efficacy of differentinfluenza vaccines in asthmatic subjects.
http://www.thoracic.org/sections/publications/press-releases/conference/articles/2009/abstracts-and-press-releases/joshi.pdf
No comments:
Post a Comment